We are live on ! Find out more
WST icon

West Pharmaceutical
WST

747 hedge funds and large institutions have $22.9B invested in West Pharmaceutical in 2024 Q4 according to their latest regulatory filings, with 108 funds opening new positions, 296 increasing their positions, 257 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 4 → 10 (+6)

37% more first-time investments, than exits

New positions opened: 108 | Existing positions closed: 79

15% more repeat investments, than reductions

Existing positions increased: 296 | Existing positions reduced: 257

11% more capital invested

Capital invested by funds: $20.5B → $22.9B (+$2.35B)

2% more funds holding

Funds holding: 729 → 747 (+18)

1.88% more ownership

Funds ownership: 94.55% → 96.43% (+1.9%)

44% less call options, than puts

Call options by funds: $77.4M | Put options by funds: $139M

Holders
747
Holders Change
+18
Holders Change %
+2.47%
% of All Funds
9.84%
Holding in Top 10
10
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+150%
% of All Funds
0.13%
New
108
Increased
296
Reduced
257
Closed
79
Calls
$77.4M
Puts
$139M
Net Calls
-$61.3M
Net Calls Change
-$1.27M

Top Buyers

Rank Fund Capital Flow
1
VanEck Associates
VanEck Associates
New York
+$213M
2
Citadel Advisors
Citadel Advisors
Florida
+$196M
3
William Blair Investment Management
William Blair Investment Management
Illinois
+$177M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$156M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$132M

Top Sellers

Rank Fund Capital Flow
1
APG Asset Management
APG Asset Management
Netherlands
-$274M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$232M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$173M
4
ProShare Advisors
ProShare Advisors
Maryland
-$168M
5
Franklin Resources
Franklin Resources
California
-$158M
Name Holding Trade Value Shares
Change 		Change in
Stake
FFO
701
Fortitude Family Office
Arizona
$3.6K – – –
PPWM
702
PFG Private Wealth Management
Florida
$3.6K – – –
FMP
703
Financial Management Professionals
Texas
$3.6K +$3.46K +11 New
CTC
704
Central Trust Company
Missouri
$3.28K -$5.67K -18 -64%
CWP
705
Clark Wealth Partners
Illinois
$3.28K +$3.15K +10 New
MMCM
706
Murphy & Mullick Capital Management
New York
$3.28K +$3.15K +10 New
FPF
707
First Pacific Financial
Washington
$2.95K +$2.83K +9 New
CAS
708
Coppell Advisory Solutions
Texas
$2.63K – – –
CFB
709
Cullen/Frost Bankers
Texas
$2.62K +$944 +3 +60%
JFA
710
JNBA Financial Advisors
Minnesota
$2.62K – – –
TAM
711
Tucker Asset Management
Colorado
$2.62K – – –
SPF
712
South Plains Financial
Texas
$2.62K +$2.52K +8 New
BCMLT
713
Beacon Capital Management LLC (Tennessee)
Tennessee
$2.29K -$315 -1 -13%
DPW
714
DiNuzzo Private Wealth
Pennsylvania
$2.29K – – –
LCM
715
Logan Capital Management
Pennsylvania
$1.99K -$3.46K -11 -65%
DJSG
716
D.J. St. Germain
Massachusetts
$1.97K – – –
CFD
717
Creative Financial Designs
Indiana
$1.97K +$1.89K +6 New
HCP
718
Hexagon Capital Partners
Arkansas
$1.97K +$1.89K +6 New
NC
719
NewSquare Capital
Pennsylvania
$1.64K +$1.57K +5 New
LIM
720
Longfellow Investment Management
Massachusetts
$1.31K – – –
WWP
721
WR Wealth Planners
Missouri
$1.31K – – –
CA
722
Continuum Advisory
Idaho
$1.31K +$315 +1 +33%
NL
723
NVWM LLC
Pennsylvania
$1.31K +$944 +3 +300%
CSWM
724
Cassady Schiller Wealth Management
Ohio
$1.31K +$1.26K +4 New
CWM
725
Crowley Wealth Management
Delaware
$1.31K +$1.26K +4 New
27 28
29
30 31

WST Hedge Fund Activity: Q4 2024 in Review

747 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q4 2024, worth a combined $22.9B — up 11% from $20.5B a quarter earlier.

Buyers outnumbered sellers: 108 funds opened new WST positions and 79 closed out — a net gain of 29 holders — while 296 added to existing stakes and 257 trimmed.

The largest buyer was VanEck Associates, adding an estimated $213M. The largest seller was APG Asset Management, cutting an estimated $274M.

  • 747 institutional investors held West Pharmaceutical (WST) as of Q4 2024, up from 729 in Q3 2024.
  • Funds reported $22.9B of West Pharmaceutical stock for Q4 2024, up 11% quarter-over-quarter.
  • 108 funds opened new West Pharmaceutical positions in Q4 2024 and 79 closed out, a net change of +29 holders.
  • The largest West Pharmaceutical buyer in Q4 2024 was VanEck Associates, an estimated $213M added.
  • The largest West Pharmaceutical seller in Q4 2024 was APG Asset Management, an estimated $274M sold.

Based on aggregated 13F filings for Q4 2024.